These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26549167)

  • 1. An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence.
    Nascimento-Carvalho CM; Andrade DC; Vilas-Boas AL
    Expert Opin Pharmacother; 2016; 17(1):53-78. PubMed ID: 26549167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of community-acquired pneumonia in young children.
    Nascimento-Carvalho AC; Nascimento-Carvalho CM
    Expert Opin Pharmacother; 2019 Mar; 20(4):435-442. PubMed ID: 30507273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of childhood pneumonia.
    Nascimento-Carvalho CM
    Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia.
    Bradley JS; McCracken GH
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S241-8. PubMed ID: 18986297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
    R Marques I; P Calvi I; A Cruz S; M F Sanchez L; F Baroni I; Oommen C; H Padrao EM; C Mari P
    Eur J Pediatr; 2022 Nov; 181(11):3795-3804. PubMed ID: 36066660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.
    Korppi M
    Paediatr Drugs; 2003; 5(12):821-32. PubMed ID: 14658923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
    Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
    Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community-acquired severe pneumonia.
    Jeena PM; Minkara AK; Corr P; Bassa F; McNally LM; Coovadia HM; Fox M; Hamer DH; Thea D
    Arch Dis Child; 2007 Nov; 92(11):976-9. PubMed ID: 17595201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
    Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
    JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment of community-acquired pneumonia.
    Liapikou A; Torres A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
    Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
    Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
    Breuer O; Blich O; Cohen-Cymberknoh M; Averbuch D; Kharasch S; Shoseyov D; Kerem E
    Pediatr Pulmonol; 2015 May; 50(5):495-502. PubMed ID: 25652187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin.
    Nascimento-Carvalho CM; Xavier-Souza G; Vilas-Boas AL; Fontoura MH; Barral A; Puolakkainen M; Ruuskanen O;
    J Antimicrob Chemother; 2017 Aug; 72(8):2378-2384. PubMed ID: 28475737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia.
    Jeena P; Thea DM; MacLeod WB; Chisaka N; Fox MP; Coovadia HM; Qazi S;
    Bull World Health Organ; 2006 Apr; 84(4):269-75. PubMed ID: 16628299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Collaborative to Improve Care of Community Acquired Pneumonia in Hospitalized Children.
    Parikh K; Biondi E; Nazif J; Wasif F; Williams DJ; Nichols E; Ralston S;
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28148730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.